+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Regenerative Medicine Market Research Report by Type, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4857893
  • Report
  • April 2022
  • Region: Global
  • 185 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022
The Global Regenerative Medicine Market size was estimated at USD 16.69 billion in 2021, USD 20.01 billion in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 20.03% to reach USD 49.94 billion by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Regenerative Medicine to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Cell-Based Immunotherapy & Cell Therapy Products, Gene Therapy Products, Small Molecule and Biologic, and Tissue-Engineered Products. The Cell-Based Immunotherapy & Cell Therapy Products is further studied across Allogeneic Products and Autologous Products.
  • Based on Application, the market was studied across Diabetes, Musculoskeletal Disorders, Ocular Disorders, Oncology, Wound Care, and Cardiovascular.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Regenerative Medicine market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Regenerative Medicine Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Regenerative Medicine Market, including Allergan plc, Amgen Inc., Gilead Sciences, Inc., Integra LifeSciences Holdings Corporation, Medtronic Plc, Mimedx Group, Novartis AG, Organogenesis Inc., Osiris Therapeutics, Inc., Smith & Nephew plc, Stryker Corporation, Takeda Pharmaceutical Co. Ltd., Vericel Corporation, Wright Medical Group N.V., and Zimmer Biomet Holdings Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Regenerative Medicine Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Regenerative Medicine Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Regenerative Medicine Market?
4. What is the competitive strategic window for opportunities in the Global Regenerative Medicine Market?
5. What are the technology trends and regulatory frameworks in the Global Regenerative Medicine Market?
6. What is the market share of the leading vendors in the Global Regenerative Medicine Market?
7. What modes and strategic moves are considered suitable for entering the Global Regenerative Medicine Market?
Frequently Asked Questions about the Global Regenerative Medicine Market

What is the estimated value of the Global Regenerative Medicine Market?

The Global Regenerative Medicine Market was estimated to be valued at $16.7 Billion in 2021.

What is the growth rate of the Global Regenerative Medicine Market?

The growth rate of the Global Regenerative Medicine Market is 20.0%, with an estimated value of $49.9 Billion by 2027.

What is the forecasted size of the Global Regenerative Medicine Market?

The Global Regenerative Medicine Market is estimated to be worth $49.9 Billion by 2027.

Who are the key companies in the Global Regenerative Medicine Market?

Key companies in the Global Regenerative Medicine Market include Allergan plc, Amgen Inc., Gilead Sciences, Inc., Integra LifeSciences Holdings Corporation, Medtronic Plc, Mimedx Group, Novartis AG, Organogenesis Inc. and Smith & Nephew plc.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing adoption of stem cell technologies, gene therapies, and tissue engineering
5.1.1.2. Technological advancements in regenerative medicine biologics, 3D bioprinting, and biomaterials
5.1.1.3. Product approval coupled with rising government investments in regenerative medicine research
5.1.2. Restraints
5.1.2.1. Ethical issues related to the use of embryonic stem cells in R&D
5.1.3. Opportunities
5.1.3.1. Growing demand for organ transplantation and bone grafting
5.1.3.2. Increasing R&D activities by private players coupled with the involvement of academic institutes for research
5.1.4. Challenges
5.1.4.1. Regulatory issues pertaining to stem cell, tissues engineering and regenerative medicine
5.1.4.2. High cost associated with treatment
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Regenerative Medicine Market, by Type
6.1. Introduction
6.2. Cell-Based Immunotherapy & Cell Therapy Products
6.2.1. Allogeneic Products
6.2.2. Autologous Products
6.3. Gene Therapy Products
6.4. Small Molecule and Biologic
6.5. Tissue-Engineered Products
7. Regenerative Medicine Market, by Application
7.1. Introduction
7.2. Diabetes
7.3. Musculoskeletal Disorders
7.4. Ocular Disorders
7.5. Oncology
7.6. Wound Care
7.7. Cardiovascular
8. Americas Regenerative Medicine Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Regenerative Medicine Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
10. Europe, Middle East & Africa Regenerative Medicine Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Allergan plc
12.2. Amgen Inc.
12.3. Gilead Sciences, Inc.
12.4. Integra LifeSciences Holdings Corporation
12.5. Medtronic Plc
12.6. Mimedx Group
12.7. Novartis AG
12.8. Organogenesis Inc.
12.9. Osiris Therapeutics, Inc.
12.10. Smith & Nephew plc
12.11. Stryker Corporation
12.12. Takeda Pharmaceutical Co. Ltd.
12.13. Vericel Corporation
12.14. Wright Medical Group N.V.
12.15. Zimmer Biomet Holdings Inc.
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL REGENERATIVE MEDICINE MARKET: DYNAMICS
FIGURE 2. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 3. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2027
FIGURE 5. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2019-2027 (USD BILLION)
FIGURE 6. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 7. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY ALLOGENEIC PRODUCTS, 2019-2027 (USD BILLION)
FIGURE 8. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY ALLOGENEIC PRODUCTS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 9. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY AUTOLOGOUS PRODUCTS, 2019-2027 (USD BILLION)
FIGURE 10. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY AUTOLOGOUS PRODUCTS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 11. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY GENE THERAPY PRODUCTS, 2019-2027 (USD BILLION)
FIGURE 12. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY GENE THERAPY PRODUCTS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY SMALL MOLECULE AND BIOLOGIC, 2019-2027 (USD BILLION)
FIGURE 14. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY SMALL MOLECULE AND BIOLOGIC, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 15. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TISSUE-ENGINEERED PRODUCTS, 2019-2027 (USD BILLION)
FIGURE 16. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TISSUE-ENGINEERED PRODUCTS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 17. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 18. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD BILLION)
FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2027
FIGURE 20. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY DIABETES, 2019-2027 (USD BILLION)
FIGURE 21. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY DIABETES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 22. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, 2019-2027 (USD BILLION)
FIGURE 23. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 24. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY OCULAR DISORDERS, 2019-2027 (USD BILLION)
FIGURE 25. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY OCULAR DISORDERS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 26. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, 2019-2027 (USD BILLION)
FIGURE 27. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 28. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY WOUND CARE, 2019-2027 (USD BILLION)
FIGURE 29. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY WOUND CARE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 30. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR, 2019-2027 (USD BILLION)
FIGURE 31. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 32. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 33. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 34. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 35. CANADA REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 36. MEXICO REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 37. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 38. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 39. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 40. CHINA REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 41. INDIA REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 42. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 43. JAPAN REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 44. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 45. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 46. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 47. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 48. TAIWAN REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 49. THAILAND REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 50. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 51. FRANCE REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 52. GERMANY REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 53. ITALY REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 54. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 55. QATAR REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 56. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 57. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 58. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 59. SPAIN REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 60. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 61. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 62. GLOBAL REGENERATIVE MEDICINE MARKET: FPNV POSITIONING MATRIX
FIGURE 63. GLOBAL REGENERATIVE MEDICINE MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 64. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL REGENERATIVE MEDICINE MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL REGENERATIVE MEDICINE MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 4. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, BY REGION, 2019-2027 (USD BILLION)
TABLE 5. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 6. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, BY STATE, 2019-2027 (USD BILLION)
TABLE 7. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 9. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY ALLOGENEIC PRODUCTS, BY REGION, 2019-2027 (USD BILLION)
TABLE 10. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY ALLOGENEIC PRODUCTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 11. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY ALLOGENEIC PRODUCTS, BY STATE, 2019-2027 (USD BILLION)
TABLE 12. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY ALLOGENEIC PRODUCTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY ALLOGENEIC PRODUCTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 14. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY AUTOLOGOUS PRODUCTS, BY REGION, 2019-2027 (USD BILLION)
TABLE 15. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY AUTOLOGOUS PRODUCTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 16. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY AUTOLOGOUS PRODUCTS, BY STATE, 2019-2027 (USD BILLION)
TABLE 17. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY AUTOLOGOUS PRODUCTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY AUTOLOGOUS PRODUCTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 19. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY GENE THERAPY PRODUCTS, BY REGION, 2019-2027 (USD BILLION)
TABLE 20. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY GENE THERAPY PRODUCTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 21. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY GENE THERAPY PRODUCTS, BY STATE, 2019-2027 (USD BILLION)
TABLE 22. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY GENE THERAPY PRODUCTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY GENE THERAPY PRODUCTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 24. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY SMALL MOLECULE AND BIOLOGIC, BY REGION, 2019-2027 (USD BILLION)
TABLE 25. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY SMALL MOLECULE AND BIOLOGIC, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 26. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY SMALL MOLECULE AND BIOLOGIC, BY STATE, 2019-2027 (USD BILLION)
TABLE 27. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY SMALL MOLECULE AND BIOLOGIC, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY SMALL MOLECULE AND BIOLOGIC, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 29. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TISSUE-ENGINEERED PRODUCTS, BY REGION, 2019-2027 (USD BILLION)
TABLE 30. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY TISSUE-ENGINEERED PRODUCTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 31. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY TISSUE-ENGINEERED PRODUCTS, BY STATE, 2019-2027 (USD BILLION)
TABLE 32. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY TISSUE-ENGINEERED PRODUCTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 33. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY TISSUE-ENGINEERED PRODUCTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 34. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 35. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY DIABETES, BY REGION, 2019-2027 (USD BILLION)
TABLE 36. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY DIABETES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 37. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY DIABETES, BY STATE, 2019-2027 (USD BILLION)
TABLE 38. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY DIABETES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY DIABETES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 40. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2019-2027 (USD BILLION)
TABLE 41. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 42. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY STATE, 2019-2027 (USD BILLION)
TABLE 43. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 45. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY OCULAR DISORDERS, BY REGION, 2019-2027 (USD BILLION)
TABLE 46. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY OCULAR DISORDERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 47. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY OCULAR DISORDERS, BY STATE, 2019-2027 (USD BILLION)
TABLE 48. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY OCULAR DISORDERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY OCULAR DISORDERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 50. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2019-2027 (USD BILLION)
TABLE 51. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 52. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, BY STATE, 2019-2027 (USD BILLION)
TABLE 53. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 55. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY WOUND CARE, BY REGION, 2019-2027 (USD BILLION)
TABLE 56. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY WOUND CARE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 57. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY WOUND CARE, BY STATE, 2019-2027 (USD BILLION)
TABLE 58. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY WOUND CARE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY WOUND CARE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 60. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2019-2027 (USD BILLION)
TABLE 61. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 62. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY STATE, 2019-2027 (USD BILLION)
TABLE 63. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 65. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 66. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 67. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 68. CANADA REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 69. MEXICO REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 70. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 71. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 72. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 73. CHINA REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 74. INDIA REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 75. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 76. JAPAN REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 77. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 78. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 79. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 80. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 81. TAIWAN REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 82. THAILAND REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 84. FRANCE REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 85. GERMANY REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 86. ITALY REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 87. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 88. QATAR REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 89. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 90. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 91. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 92. SPAIN REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 93. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 94. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 95. GLOBAL REGENERATIVE MEDICINE MARKET: SCORES
TABLE 96. GLOBAL REGENERATIVE MEDICINE MARKET: BUSINESS STRATEGY
TABLE 97. GLOBAL REGENERATIVE MEDICINE MARKET: PRODUCT SATISFACTION
TABLE 98. GLOBAL REGENERATIVE MEDICINE MARKET: RANKING
TABLE 99. GLOBAL REGENERATIVE MEDICINE MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 100. GLOBAL REGENERATIVE MEDICINE MARKET: MERGER & ACQUISITION
TABLE 101. GLOBAL REGENERATIVE MEDICINE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 102. GLOBAL REGENERATIVE MEDICINE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 103. GLOBAL REGENERATIVE MEDICINE MARKET: INVESTMENT & FUNDING
TABLE 104. GLOBAL REGENERATIVE MEDICINE MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 105. GLOBAL REGENERATIVE MEDICINE MARKET: LICENSE & PRICING

Companies Mentioned

  • Allergan plc
  • Amgen Inc.
  • Gilead Sciences, Inc.
  • Integra LifeSciences Holdings Corporation
  • Medtronic Plc
  • Mimedx Group
  • Novartis AG
  • Organogenesis Inc.
  • Osiris Therapeutics, Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • Takeda Pharmaceutical Co. Ltd.
  • Vericel Corporation
  • Wright Medical Group N.V.
  • Zimmer Biomet Holdings Inc.

Methodology

Loading
LOADING...